Bibliography
Basu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Susan Bliss, V., Manseau, E. J., Dasgupta, P. S., Dvorak, H. F., & Mukhopadhyay, D. (2001). The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nature Medicine, 7(5), 569â574.
Authors
10
- Sujit Basu (first)
- Janice A. Nagy (additional)
- Soumitro Pal (additional)
- Eliza Vasile (additional)
- Isabelle A. Eckelhoefer (additional)
- V. Susan Bliss (additional)
- Eleanor J. Manseau (additional)
- Partha S. Dasgupta (additional)
- Harold F. Dvorak (additional)
- Debabrata Mukhopadhyay (additional)
References
41
Referenced
312
- Graybiel, A.M., Hirsch, E.C. & Agid, Y. The nigrostriatal system in Parkinson's disease. Adv. Neurol. 53, 17–29 (1990). / Adv. Neurol. by AM Graybiel (1990)
-
Goldstein, M. & Deutch, A.Y. Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB J. 6, 2413–2421 (1992).
(
10.1096/fasebj.6.7.1348713
) / FASEB J. by M Goldstein (1992) -
Olanow, C.W. & Tatton, W.G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22, 123–144 (1999).
(
10.1146/annurev.neuro.22.1.123
) / Annu. Rev. Neurosci. by CW Olanow (1999) -
Egan, M.F. & Weinberger, D.R. Neurobiology of schizophrenia. Curr. Opin. Neurobiol. 7, 701–707 (1997).
(
10.1016/S0959-4388(97)80092-X
) / Curr. Opin. Neurobiol. by MF Egan (1997) -
Wick, M.M. Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. J. Invest. Dermatol. 71, 163–164 (1978).
(
10.1111/1523-1747.ep12546959.1
) / J. Invest. Dermatol. by MM Wick (1978) - Wick, M.M. 3,4-Dihydroxybenzylamine: a dopamine analog with enhanced antitumor activity against B16 melanoma. J. Natl. Cancer Inst. 63, 1465–1467 (1979). / J. Natl. Cancer Inst. by MM Wick (1979)
- Wick, M.M. Levodopa and dopamine analogs: melanin precursors as antitumor agents in experimental human and murine leukemia. Cancer Treat. Rep. 63, 991–997 (1979). / Cancer Treat. Rep. by MM Wick (1979)
- Wick, M.M. Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma. Cancer Res. 40, 1414–1418 (1980). / Cancer Res. by MM Wick (1980)
- Wick, M.M. Levodopa and dopamine analogs: dihydroxy and trihydroxybenzylamines as novel quinol antitumor agents in experimental leukemia in vivo. Cancer Treat. Rep. 65, 861–867 (1981). / Cancer Treat. Rep. by MM Wick (1981)
- Wick, M.M. & Mui, A. Synthesis and biologic evaluation of the dopamine analog N- acetyldopamine in experimental leukemia in mice. J. Natl. Cancer Inst. 66, 351–354 (1981). / J. Natl. Cancer Inst. by MM Wick (1981)
-
Dasgupta, P.S. & Lahiri, T. Antitumor effect of i.p. dopamine in mice bearing Ehrlich ascites carcinoma. J. Cancer Res. Clin. Oncol. 113, 363–368 (1987).
(
10.1007/BF00397720
) / J. Cancer Res. Clin. Oncol. by PS Dasgupta (1987) -
Basu, S. & Dasgupta, P.S. Role of dopamine in malignant tumor growth. Endocrine 12, 237–241 (2000).
(
10.1385/ENDO:12:3:237
) / Endocrine by S Basu (2000) -
Basu, S. & Dasgupta, P.S. Dopamine, a neurotransmitter, influences the immune system. J. Neuroimmunol. 102, 113–124 (2000).
(
10.1016/S0165-5728(99)00176-9
) / J. Neuroimmunol. by S Basu (2000) -
Ricci, A., Collier, W.L. & Amenta, F. Pharmacological characterization and autoradiographic localization of dopamine receptors in the portal vein. J. Auton. Pharmacol. 14, 61–68 (1994).
(
10.1111/j.1474-8673.1994.tb00590.x
) / J. Auton. Pharmacol. by A Ricci (1994) -
Bacic, F., Uematsu, S., McCarron, R.M. & Spatz, M. Dopaminergic receptors linked to adenylate cyclase in human cerebromicrovascular endothelium. J. Neurochem. 57, 1774–1780 (1991).
(
10.1111/j.1471-4159.1991.tb06380.x
) / J. Neurochem. by F Bacic (1991) -
Brown, L. et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. in Regulation of Angiogenesis (eds. Goldberg, I. & Rosen, E.) (Birkhauser, Basel, Switzerland, 1997).
(
10.1007/978-3-0348-9006-9_10
) - Dvorak, H.F., Nagy, J.A., Feng, D., Brown, L.F. & Dvorak, A.M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 237, 97–132 (1999). / Curr. Top. Microbiol. Immunol. by HF Dvorak (1999)
- Nagy, J. et al. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling and stroma formation in the peritoneal lining. Cancer Res. 55, 376–385 (1995). / Cancer Res. by J Nagy (1995)
- Nagy, J.A., Meyers, M.S., Masse, E.M., Herzberg, K.T. & Dvorak, H.F. Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity. Cancer Res. 55, 369–375 (1995). / Cancer Res. by JA Nagy (1995)
- Nagy, J.A. et al. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability and ascites fluid accumulation. Cancer Res. 55, 360–368 (1995). / Cancer Res. by JA Nagy (1995)
- Zaroslinski, J.F. et al. The pharmacology and subacute toxicology of dopamine. Proc. R. Soc. Med. 70, 2–6 (1977). / Proc. R. Soc. Med. by JF Zaroslinski (1977)
-
Dvorak, H.F. et al. Induction of a fibrin-gel investment: An early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J. Immunol. 122, 166–174 (1979).
(
10.4049/jimmunol.122.1.166
) / J. Immunol. by HF Dvorak (1979) -
Senger, D.R. et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983–985 (1983).
(
10.1126/science.6823562
) / Science by DR Senger (1983) -
Murohara, T. et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97, 99–107 (1998).
(
10.1161/01.CIR.97.1.99
) / Circulation by T Murohara (1998) -
Pettersson, A. et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab. Invest. 80, 99–115 (2000).
(
10.1038/labinvest.3780013
) / Lab. Invest. by A Pettersson (2000) - Ferrara, N. Vascular endothelial growth factor: molecular and biological aspects. Curr. Top. Microbiol. Immunol. 237, 1–30 (1999). / Curr. Top. Microbiol. Immunol. by N Ferrara (1999)
-
Ewing, A.G., Bigelow, J.C. & Wightman, R.M. Direct in vivo monitoring of dopamine released from two striatal compartments in the rat. Science 221, 169–171 (1983).
(
10.1126/science.6857277
) / Science by AG Ewing (1983) -
Heeg, K., Reimann, J., Kabelitz, D., Hardt, C. & Wagner, H. A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies. J. Immunol. Methods 77, 237–246 (1985).
(
10.1016/0022-1759(85)90036-5
) / J. Immunol. Methods by K Heeg (1985) -
Turner, H.E. et al. Angiogenesis in pituitary adenomas—relationship to endocrine function, treatment and outcome. J. Endocrinol. 165, 475–481 (2000).
(
10.1677/joe.0.1650475
) / J. Endocrinol. by HE Turner (2000) -
Takechi, A. Effect of angiogenesis inhibitor TNP-470 on vascular formation in pituitary tumors induced by estrogen in rats. Neurol. Med. Chir. 34, 729–733 (1994).
(
10.2176/nmc.34.729
) / Neurol. Med. Chir. by A Takechi (1994) -
Nagai, Y. et al. Plasma levels of vascular endothelial growth factor in patients with acromegaly. Horm. Metab. Res. 32, 326–329 (2000).
(
10.1055/s-2007-978645
) / Horm. Metab. Res. by Y Nagai (2000) -
Berkman, R.A., & Oldfield, R.H. Expression of vascular permeability factor / vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest. 91, 153–159 (1993).
(
10.1172/JCI116165
) / J. Clin. Invest. by RA Berkman (1993) -
Otsuka, F. et al. Quantitative analysis of growth - related factors in human pituitary adenomas. Lowered insulin-like growth factor-I and its receptor mRNA in growth hormone-producing adenomas. Regul. Pept. 83, 31–38 (1999).
(
10.1016/S0167-0115(99)00048-8
) / Regul. Pept. by F Otsuka (1999) -
Heaney, A.P., Horwitz, G.A., Wang, Z., Singson, R. & Melmed, S. Early involvement of estrogen induced pituitary transforming gene and fibroblast growth expression in prolactinoma pathogenesis. Nature Med. 5, 1317–1321 (1999).
(
10.1038/15275
) / Nature Med. by AP Heaney (1999) -
Ashraf, S. et al. Blood vessels in liver metastasis from both sarcoma and carcinoma lack perivascular innervation and smooth muscle cells. Clin. Exp. Metastasis. 15, 484–498 (1997).
(
10.1023/A:1018466608614
) / Clin. Exp. Metastasis. by S Ashraf (1997) -
Chamary, V.L., Robson, T., Loizidou, M., Boulos, P.B. & Burnstock, G. Progressive loss of perivascular nerves adjacent to colorectal cancer. Eur. J. Surg. Oncol. 26, 588–593 (2000).
(
10.1053/ejso.2000.0952
) / Eur. J. Surg. Oncol. by VL Chamary (2000) - Pereira da Silva, J.A., & Carmo-Fonseca, M. Peptide containing nerves in human synovium: immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J. Rheumatol. 17, 1592–1599 (1990). / J. Rheumatol. by JA Pereira da Silva (1990)
-
Miller, L.E., Justen, H.P., Scholmerich, J. & Straub, R.H. The loss of sympathetic nerve fibres in the synovial tissue of patients is accompanied by increased norepinephrine release from synovial macrophages. FASEB J. 14, 2097–2107 (2000).
(
10.1096/fj.99-1082com
) / FASEB J. by LE Miller (2000) -
Basu, S. & Dasgupta, P.S. Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue. Dig. Dis. Sci. 44, 916–921 (1999).
(
10.1023/A:1026644110737
) / Dig. Dis. Sci. by S Basu (1999) -
Braunwald, E. Evolution of the management of acute myocardial infarction: a 20th century saga. Lancet 352, 1771–1774 (1998).
(
10.1016/S0140-6736(98)03212-7
) / Lancet by E Braunwald (1998) - Katzung, B. (ed.) Basic and Clinical Pharmacology. (Appleton and Lange, Stamford, Connecticut, 1998).
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 4:43 a.m.) |
Deposited | 2 years, 3 months ago (May 18, 2023, 6:25 p.m.) |
Indexed | 6 days, 12 hours ago (Aug. 23, 2025, 12:58 a.m.) |
Issued | 24 years, 3 months ago (May 1, 2001) |
Published | 24 years, 3 months ago (May 1, 2001) |
Published Online | 24 years, 3 months ago (May 1, 2001) |
Published Print | 24 years, 3 months ago (May 1, 2001) |
@article{Basu_2001, title={The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor}, volume={7}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/87895}, DOI={10.1038/87895}, number={5}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Basu, Sujit and Nagy, Janice A. and Pal, Soumitro and Vasile, Eliza and Eckelhoefer, Isabelle A. and Susan Bliss, V. and Manseau, Eleanor J. and Dasgupta, Partha S. and Dvorak, Harold F. and Mukhopadhyay, Debabrata}, year={2001}, month=may, pages={569–574} }